Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
Rhea-AI Summary
Resmed (NYSE: RMD) will open a new distribution center in Greenwood, Indiana, scheduled to begin operations in 2027. The facility is expected to employ more than 100 full-time and contingent workers and will complement centers in Atlanta and Moreno Valley.
The Greenwood hub will raise two-day transit coverage across North America from 75% to 90% and shorten deliveries to Canada by one day, strengthening U.S. distribution capacity and local job creation.
Positive
- Two-day transit coverage improved from 75% to 90%
- Delivery to Canada shortened by one full day
- Employment of more than 100 full-time and contingent workers
- Operational start scheduled for 2027 to expand U.S. footprint
Negative
- None.
News Market Reaction – RMD
In the Feb 24 session, RMD declined 3.51%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 29 | Q2 2026 earnings | Positive | -0.0% | Double-digit revenue and EPS growth with higher gross margins. |
| Jan 08 | Earnings date notice | Neutral | +0.6% | Announcement of Q2 FY2026 results reporting date and webcast details. |
| Dec 18 | Conference participation | Neutral | +1.0% | Planned presentation at the 44th Annual J.P. Morgan Healthcare Conference. |
| Dec 08 | FDA device clearance | Positive | -2.5% | FDA clearance for AI-enabled Smart Comfort CPAP personalization feature. |
| Oct 30 | Q1 2026 earnings | Positive | -0.5% | Q1 FY2026 revenue and gross margin expansion with strong EPS and cash flow. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Operational and clinical positives, including earnings beats and FDA clearance, have often seen flat or negative next-day moves, suggesting a tendency toward muted or contrarian price reactions to good news.
Over the last few months, ResMed reported strong FY2026 Q1 and Q2 results, with revenue above $1.3B in each quarter and gross margins above 61%. The company also gained FDA clearance for its AI-enabled Smart Comfort device and participated in major industry conferences. Despite these fundamentally positive milestones, next-day price reactions were typically flat to slightly negative. Today’s announcement of a new Greenwood, Indiana distribution center continues the theme of operational investment aimed at efficiency and North American service expansion.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience
SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed’s U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America.
The Greenwood center will operate as a major logistics hub, enhancing the delivery of essential healthcare products across North America while reinforcing Resmed’s commitment to the local Greenwood community. It's estimated that the facility will employ more than 100 full-time and contingent workers over time across operations, logistics and management. Resmed is working closely with local and state partners, including the State of Indiana and the City of Greenwood, to support job creation and advance the project.
The Greenwood center complements Resmed’s existing distribution centers in Atlanta, Georgia and Moreno Valley, California. Its central location will connect coastal operations and support ongoing improvements in efficiency, productivity and delivery speed. Once fully operational, it will improve two-day transit coverage across North America from
“We’re proud to grow our U.S. footprint and invest in the local Greenwood community,” said Shane Azzi, chief supply chain officer at Resmed. “Greenwood’s talented workforce and strong spirit of collaboration played a major role in our decision to locate here. The new distribution center will help us deliver products more quickly, strengthen our ability to serve patients and providers and support the region’s long term growth.”
"Indiana’s life sciences sector continues to attract new global and innovative leaders to the state,” said Indiana Governor Mike Braun. “Here in the crossroads of the U.S., Resmed will be centrally located and have access to robust infrastructure, helping the company serve customers more quickly and deliver life-changing solutions.”
“Resmed’s decision to locate in Greenwood is a win for our residents and our local economy,” said Mark W. Myers, Mayor of Greenwood. “This investment reflects our pride in bringing high-quality jobs to Greenwood and expanding the region’s role in delivering essential healthcare products nationwide. We’re grateful that Resmed chose Greenwood as the home for this new operation.”
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For Media | For Investors |
| Caela Shay | Salli Schwartz |
| caela.shay@resmed.com | salli.schwartz@resmed.com |
| news@resmed.com | investorrelations@resmed.com |
